These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31911024)

  • 41. New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic.
    Lo Faro AF; Berardinelli D; Cassano T; Dendramis G; Montanari E; Montana A; Berretta P; Zaami S; Busardò FP; Huestis MA
    Biology (Basel); 2023 Feb; 12(2):. PubMed ID: 36829550
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The clinical challenges of synthetic cathinones.
    Schifano F; Napoletano F; Arillotta D; Zangani C; Gilgar L; Guirguis A; Corkery JM; Vento A
    Br J Clin Pharmacol; 2020 Mar; 86(3):410-419. PubMed ID: 31674690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New Psychoactive Substances (NPS) - a Challenge for the Addiction Treatment Services.
    Scherbaum N; Schifano F; Bonnet U
    Pharmacopsychiatry; 2017 May; 50(3):116-122. PubMed ID: 28444659
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The rise of new psychoactive substance use in Australia.
    Burns L; Roxburgh A; Matthews A; Bruno R; Lenton S; Van Buskirk J
    Drug Test Anal; 2014; 6(7-8):846-9. PubMed ID: 24599890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of synthetic stimulants and hallucinogens in a cohort of electronic dance music festival attendees.
    Mohr ALA; Friscia M; Yeakel JK; Logan BK
    Forensic Sci Int; 2018 Jan; 282():168-178. PubMed ID: 29216523
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project.
    Helander A; Bäckberg M; Hultén P; Al-Saffar Y; Beck O
    Forensic Sci Int; 2014 Oct; 243():23-9. PubMed ID: 24726531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of new psychoactive substances to mimic prescription drugs: The trend in France.
    Batisse A; Eiden C; Peyriere H; Djezzar S;
    Neurotoxicology; 2020 Jul; 79():20-24. PubMed ID: 32240674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States.
    Palamar JJ; Barratt MJ; Ferris JA; Winstock AR
    Am J Addict; 2016 Aug; 25(5):400-7. PubMed ID: 27419383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.
    Mounteney J; Griffiths P; Sedefov R; Noor A; Vicente J; Simon R
    Addiction; 2016 Jan; 111(1):34-48. PubMed ID: 26419329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human Toxicity Caused by Indole and Indazole Carboxylate Synthetic Cannabinoid Receptor Agonists: From Horizon Scanning to Notification.
    Hill SL; Dunn M; Cano C; Harnor SJ; Hardcastle IR; Grundlingh J; Dargan PI; Wood DM; Tucker S; Bartram T; Thomas SHL
    Clin Chem; 2018 Feb; 64(2):346-354. PubMed ID: 29038156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins.
    Banister SD; Connor M
    Handb Exp Pharmacol; 2018; 252():165-190. PubMed ID: 29980914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patterns of Acute Toxicity Associated with New Psychoactive Substances.
    Hill SL; Dargan PI
    Handb Exp Pharmacol; 2018; 252():475-494. PubMed ID: 29896654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spicing it up - synthetic cannabinoid receptor agonists and psychosis - a systematic review.
    Hobbs M; Kalk NJ; Morrison PD; Stone JM
    Eur Neuropsychopharmacol; 2018 Dec; 28(12):1289-1304. PubMed ID: 30454908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act.
    Craft S; Dunn M; Vidler D; Officer J; Blagbrough IS; Pudney CR; Henderson G; Abouzeid A; Dargan PI; Eddleston M; Cooper J; Hill SL; Roper C; Freeman TP; Thomas SHL
    Addiction; 2022 Nov; 117(11):2899-2906. PubMed ID: 35665553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Consideration of the influence of place on access to employment for persons with serious mental illness in northeastern Ontario.
    Rebeiro Gruhl KL; Kauppi C; Montgomery P; James S
    Rural Remote Health; 2012; 12():2034. PubMed ID: 22839731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evolution of clinical characteristics and outcomes of synthetic cannabinoid receptor agonist exposure in the United States: analysis of National Poison Data System data from 2010 to 2015.
    Cordeiro SK; Daro RC; Seung H; Klein-Schwartz W; Kim HK
    Addiction; 2018 Oct; 113(10):1850-1861. PubMed ID: 29806885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute neurological consequences of novel psychoactive substance use: a retrospective review in a large UK hospital.
    Tanti M; Cosgrove J; Kelleher C; Jones R; Maguire M
    Clin Med (Lond); 2021 May; 21(3):189-194. PubMed ID: 33947659
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent Use of Synthetic Cannabinoids, Synthetic Opioids, and Other Psychoactive Drug Groups among High-risk Drug Users.
    Shapira B; Berkovitz R; Rosca P; Neumark Y
    J Psychoactive Drugs; 2020; 52(4):334-343. PubMed ID: 32345134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel psychoactive substance and other drug use by young adults in Western australia.
    Goggin LS; Gately N; Bridle RI
    J Psychoactive Drugs; 2015; 47(2):140-8. PubMed ID: 25950594
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Health and Social Care workers' perceptions of NPS use in Northern Ireland.
    Campbell A; O Neill N; Higgins K
    Int J Drug Policy; 2017 Feb; 40():93-101. PubMed ID: 27939297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.